Ketamine analogues for treatment of thrombocytopenia

Patent Number: 5384331

Date of First Priority Issue: Thursday July 18th, 1991

Date Issued: Tuesday January 24th, 1995

Assignee: Genentech, Inc. (San Francisco, CA)

Inventors: Kogan, Timothy P. (Half Moon Bay, CA); Somers, Todd C. (Montara, CA)

From Class: Differentiation

Comments: No comments

Ketamine is used as an anasthetic in veterinary medicine, as well as for some human uses. This patent teaches various chemical modifications of ketamine that stimulate production of stem cells that are committed to generating platelets.

The importance of stimulating platelet production is seen by the number of companies working on either thrombopoietin analogues or antibodies to the thrombopoietic receptor that are activatory.

View this patent on the USPTO website.

Added to StemCellPatents.com on Monday October 16th, 2006

Social & Bookmarking: